Antibiotic Susceptibility Patterns in Patients with Chronic Kidney Disease in Bangladesh: A Comprehensive Analysis of Clinical Isolates
Abstract
Chronic kidney disease (CKD) is a significant health concern in Bangladesh, with patients frequently experiencing infectious complications due to immunocompromised status. The study aimed to investigate the antibiotic susceptibility patterns among patients with chronic kidney disease (CKD) in Bangladesh. This cross-sectional study was conducted at Jalalabad Ragib-Rabeya Medical College in Sylhet, Bangladesh, from June 2022 to May 2023. Through a comprehensive analysis of clinical isolates from 205 CKD patients, the study reveals varying susceptibility profiles across multiple antibiotics. Among the antibiotics tested, carbapenems, specifically, meropenem and imipenem, exhibit high sensitivity rates exceeding 88% against diverse microbial isolates. This highlights their efficacy as broad-spectrum agents. Amikacin, on the other hand, emerges as a reliable treatment option, showing substantial sensitivity ranging from 50% to 100% against most isolates. Other antibiotics, such as ciprofloxacin and levofloxacin, demonstrate moderate to high sensitivity. They are particularly effective against prevalent pathogens like Escherichia coli and Pseudomonas. However, some antibiotics, including ceftazidime and cefuroxime, show limited efficacy against specific isolates. These findings underscore the importance of judicious antibiotic selection and surveillance in CKD patients. Such measures are crucial for optimising treatment outcomes and minimising antibiotic resistance. The study also…
How strong is the evidence?
Evidence Hub reads this as a cross-sectional, done in people. Its evidence level is 4 of 5 (Low · observational). Observational designs can show an association but not prove cause. Reported size: 205 participants or records.
Read the paper
Related studies
- Penicillins for Treatment of Pneumococcal Pneumonia: Does In Vitro Resistance Really Matter?
- Thiophenes—Naturally Occurring Plant Metabolites: Biological Activities and In Silico Evaluation of Their Potential as Cathepsin D Inhibitors
- Inhalable Mannosylated Rifampicin–Curcumin Co-Loaded Nanomicelles with Enhanced In Vitro Antimicrobial Efficacy for an Optimized Pulmonary Tuberculosis Therapy
- Development and validation of microbial bioassay for quantification of Levofloxacin in pharmaceutical preparations
- GC-MS Analysis and Biomedical Therapy of Oil from n-Hexane Fraction of Scutellaria edelbergii Rech. f.: In Vitro, In Vivo, and In Silico Approach
- Propranolol, chlorpromazine and diclofenac restore susceptibility of extensively drug-resistant (XDR)-Acinetobacter baumannii to fluoroquinolones
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.